Toxic effects of methylmercury, arsanilic acid and danofloxacin on the differentiation of mouse embryonic stem cells into neural cells

Journal of Veterinary Science

Volumn 15, Issue 1, 2014, Pages 61-71

  Kang, Seok Jin ^a   Jeong, Sang Hee ^b   Kim, Eun Joo ^a   Park, Young Il ^a   Park, Sung Won ^a   Shin, Hyo Sook ^a   Son, Seong Wan ^a   Kang, Hwan Goo ^a  

^a Animal Plant and Fisheries Quarantine and Inspection Agency   (South Korea)

^b Hoseo University   (South Korea)

Author keywords

Arsanilic acid; Danofloxacin; Embryonic stem cell test; Methylmercury; Neural cell

Indexed keywords

ACETYLCHOLINESTERASE; ARSANILIC ACID; DANOFLOXACIN; METHYLMERCURY DERIVATIVE; NERVE PROTEIN; POLLUTANT; QUINOLONE DERIVATIVE; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE;

ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECTS; EMBRYONIC STEM CELL; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; METABOLISM; MOUSE; NERVE CELL; POLLUTANT; TOXICITY;

ACETYLCHOLINESTERASE; ANIMALS; ARSANILIC ACID; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; ENVIRONMENTAL POLLUTANTS; FLUORESCENT ANTIBODY TECHNIQUE; FLUOROQUINOLONES; GENE EXPRESSION REGULATION; METHYLMERCURY COMPOUNDS; MICE; NERVE TISSUE PROTEINS; NEURONS; TETRAZOLIUM SALTS; THIAZOLES;

EID: 84896387617     PISSN: 1229845X     EISSN: 1976555X     Source Type: Journal    
DOI: 10.4142/jvs.2014.15.1.61     Document Type: Article

References (39)

1. Aschner M, Aschner JL. Mercury neurotoxicity: mechanisms of blood-brain barrier transport. Neurosci Biobehav Rev 1990, 14, 169-176.
2. Baek DH, Kim TG, Lim HK, Kang JW, Seong SK, Choi SE, Lim SY, Park SH, Nam B, Kim EH, Kim MS, Park KL. Embryotoxicity assessment of developmental neurotoxicants using a neuronal endpoint in the embryonic stem cell test. J Appl Toxicol 2012, 32, 617-626.
3. Bain G, Kitchens D, Yao M, Huettner JE, Gottlieb DI. Embryonic stem cells express neuronal properties in vitro. Dev Biol 1995, 168, 342-357.
4. Basu N, Scheuhammer AM, Rouvinen-Watt K, Evans RD, Trudeau VL, Chan LHM. In vitro and whole animal evidence that methylmercury disrupts GABAergic systems in discrete brain regions in captive mink. Comp Biochem Physiol C Toxicol Pharmacol 2010, 151, 379-385.
5. Becker B, Antoine MH, Nguyen QA, Rigo B, Cosgrove KE, Barnes PD, Dunne MJ, Pirotte B, Lebrun P. Synthesis and characterization of a quinolinonic compound activating ATP-sensitive K+ channels in endocrine and smooth muscle tissues. Br J Pharmacol 2001, 134, 375-385.
6. Brubaker PE, Klein R, Herman SP, Lucier GW, Alexander LT, Long MD. DNA, RNA, and protein synthesis in brain, liver, and kidneys of asymptomatic methylmercury treated rats. Exp Mol Pathol 1973, 18, 263-280.
7. Choi BH. Effects of methylmercury on neuroepithelial germinal cells in the developing telencephalic vesicles of mice. Acta Neuropathol 1991, 81, 359-365.
8. Christ W. Central nervous system toxicity of quinolones: human and animal findings. J Antimicrob Chemother 1990, 26 (Suppl B), 219-225.
9. Davey PG, Charter M, Kelly S, Varma TRK, Jacobson I, Freeman A, Precious E, Lambert J. Ciprofloxacin and sparfloxacin penetration into human brain tissue and their activity as antagonists of GABAA receptor of rat vagus nerve. Antimicrob Agents Chemother 1994, 38, 1356-1362.
10. Eng LF, Ghirnikar RS, Lee YL. Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem Res 2000, 25, 1439-1451.
11. Ferm VH. Arsenic as a teratogenic agent. Environ Health Perspect 1977, 19, 215-217.
12. Genschow E, Spielmann H, Scholz G, Pohl I, Seiler A, Clemann N, Bremer S, Becker K. Validation of the embryonic stem cell test in the international ECVAM validation study on three in vitro embryotoxicity tests. Altern Lab Anim 2004, 32, 209-244.
13. Genschow E, Spielmann H, Scholz G, Seiler A, Brown N, Piersma A, Brady M, Clemann N, Huuskonen H, Paillard F, Bremer S, Becker K. The ECVAM international validation study on in vitro embryotoxicity tests: results of the definitive phase and evaluation of prediction models. Altern Lab Anim 2002, 30, 151-176.
14. Graff RD, Falconer MM, Brown DL, Reuhl KR. Altered sensitivity of posttranslationally modified microtubules to methylmercury in differentiating embryonal carcinomaderived neurons. Toxicol Appl Pharmacol 1997, 144, 215-224.
15. Hogberg HT, Kinsner-Ovaskainen A, Coecke S, Hartung T, Bal-Price AK. mRNA expression is a relevant tool to identify developmental neurotoxicants using an in vitro approach. Toxicol Sci 2010, 113, 95-115.
16. Kang SJ, Jeong SH, Kim EJ, Cho JH, Park YI, Park SW, Shin HS, Son SW, Kang HG. Evaluation of hepatotoxicity of chemicals using hepatic progenitor and hepatocyte-like cells derived from mouse embryonic stem cells: effect of chemicals on ESC-derived hepatocyte differentiation. Cell Biol Toxicol 2013, 29, 1-11.
17. Kawasaki H, Mizuseki K, Nishikawa S, Kaneko S, Kuwana Y, Nakanishi S, Nishikawa SI, Sasai Y. Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 2000, 28, 31-40.
18. Ko JY, Lee HS, Park CH, Koh HC, Lee YS, Lee SH. Conditions for tumor-free and dopamine neuron-enriched grafts after transplanting human ES cell-derived neural precursor cells. Mol Ther 2009, 17, 1761-1770.
19. Lindgren A, Danielsson BRG, Dencker L, Vahter M. Embryotoxicity of arsenite and arsenate: distribution in pregnant mice and monkeys and effects on embryonic cells in vitro. Acta Pharmacol Toxicol (Copenh) 1984, 54, 311-320.
20. Matus A, Bernhardt R, Hugh-Jones T. High molecular weight microtubule-associated proteins are preferentially associated with dendritic microtubules in brain. Proc Natl Acad Sci U S A 1981, 78, 3010-3014.
21. Memberg SP, Hall AK. Dividing neuron precursors express neuron-specific tubulin. J Neurobiol 1995, 27, 26-43.
22. Mujtaba T, Piper DR, Kalyani A, Groves AK, Lucero MT, Rao MS. Lineage-restricted neural precursors can be isolated from both the mouse neural tube and cultured ES cells. Dev Biol 1999, 214, 113-127.
23. Niwa H, Miyazaki J, Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 2000, 24, 372-376.
24. Rambhatla L, Chiu CP, Kundu P, Peng Y, Carpenter MK. Generation of hepatocyte-like cells from human embryonic stem cells. Cell Transplant 2003, 12, 1-11.
25. Rodier PM. Developing brain as a target of toxicity. Environ Health Perspect 1995, 103 (Suppl 6), 73-76.
26. Sarafian T, Verity MA. Oxidative mechanisms underlying methyl mercury neurotoxicity. Int J Dev Neurosci 1991, 9, 147-153.
27. Schambra UB, Sulik KK, Petrusz P, Lauder JM. Ontogeny of cholinergic neurons in the mouse forebrain. J Comp Neurol 1989, 288, 101-122.
28. Shin S, Mitalipova M, Noggle S, Tibbitts D, Venable A, Rao R, Stice SL. Long-term proliferation of human embryonic stem cell-derived neuroepithelial cells using defined adherent culture conditions. Stem Cells 2006, 24, 125-138.
29. St Clair DM, Brock DJH, Barron L. A monoclonal antibody assay technique for plasma and red cell acetylcholinesterase activity in Alzheimer's disease. J Neurol Sci 1986, 73, 169-176.
30. Stummann TC, Hareng L, Bremer S. Embryotoxicity hazard assessment of methylmercury and chromium using embryonic stem cells. Toxicology 2007, 242, 130-143.
31. Stummann TC, Hareng L, Bremer S. Hazard assessment of methylmercury toxicity to neuronal induction in embryogenesis using human embryonic stem cells. Toxicology 2009, 257, 117-126.
32. Takeuchi IK. Embryotoxicity of arsenic acid: light and electron microscopy of its effect on neurulation-stage rat embryo. J Toxicol Sci 1979, 4, 405-416.
33. Tamm C, Duckworth J, Hermanson O, Ceccatelli S. High susceptibility of neural stem cells to methylmercury toxicity: effects on cell survival and neuronal differentiation. J Neurochem 2006, 97, 69-78.
34. Vidarsson H, Hyllner J, Sartipy P. Differentiation of human embryonic stem cells to cardiomyocytes for in vitro and in vivo applications. Stem Cell Rev 2010, 6, 108-120.
35. Voigtländer T, Friedl W, Cremer M, Schmidt W, Schroeder TM. Quantitative and qualitative assay of amniotic-fluid acetylcholinesterase in the prenatal diagnosis of neural tube defects. Hum Genet 1981, 59, 227-231.
36. Wlodraczyk B, Bennett GD, Calvin JA, Craig JC, Finnell RH. Arsenic-induced alterations in embryonic transcription factor gene expression: implications for abnormal neural development. Dev Genet 1996, 18, 306-315.
37. Wlodarczyk BJ, Bennett GD, Calvin JA, Finnell RH. Arsenic-induced neural tube defects in mice: alterations in cell cycle gene expression. Reprod Toxicol 1996, 10, 447-454.
38. Ying QL, Stavridis M, Griffiths D, Li M, Smith A. Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture. Nat Biotechnol 2003, 21, 183-186.
39. Zhang SC, Wernig M, Duncan ID, Brüstle O, Thomson JA. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol 2001, 19, 1129-1133.